ACS Medicinal Chemistry Letters p. 697 - 701 (2016)
Update date:2022-08-05
Topics:
Tang, Haifeng
Zhu, Yuping
Teumelsan, Nardos
Walsh, Shawn P.
Shahripour, Aurash
Priest, Birgit T.
Swensen, Andrew M.
Felix, John P.
Brochu, Richard M.
Bailey, Timothy
Thomas-Fowlkes, Brande
Pai, Lee-Yuh
Hampton, Caryn
Corona, Aaron
Hernandez, Melba
Metzger, Joseph
Forrest, Michael
Zhou, Xiaoyan
Owens, Karen
Tong, Vincent
Parmee, Emma
Roy, Sophie
Kaczorowski, Gregory J.
Yang, Lihu
Alonso-Galicia, Magdalena
Garcia, Maria L.
Pasternak, Alexander
ROMK, the renal outer medullary potassium channel, is involved in potassium recycling at the thick ascending loop of Henle and potassium secretion at the cortical collecting duct in the kidney nephron. Because of this dual site of action, selective inhibitors of ROMK are expected to represent a new class of diuretics/natriuretics with superior efficacy and reduced urinary loss of potassium compared to standard-of-care loop and thiazide diuretics. Following our earlier work, this communication will detail subsequent medicinal chemistry endeavors to further improve lead selectivity against the hERG channel and preclinical pharmacokinetic properties. Pharmacological assessment of highlighted inhibitors will be described, including pharmacodynamic studies in both an acute rat diuresis/natriuresis model and a subchronic blood pressure model in spontaneous hypertensive rats. These proof-of-biology studies established for the first time that the human and rodent genetics accurately predict the in vivo pharmacology of ROMK inhibitors and supported identification of the first small molecule ROMK inhibitor clinical candidate, MK-7145.
View MoreLanzhou huibang biological chemical technology Co., LTD
Contact:0931-7843964
Address:NO.2011,Yannan Road,Chengguan,
Shenzhen HwaGen Pharmaceutical Co., Ltd
website:http://www.rafflespt.com
Contact:+86-752-5538396
Address:Guangdong Huizhou China
Shanghai Norky Pharmaceutical Co., LTD.
website:http://www.norkypharm.com
Contact:86-21-61075300
Address:1165 Jiangning Road, Office 1502, Shanghai, China
Chengdu NoVi Biotechnology Co., Ltd.(expird)
Contact:13551243286/028-81458053
Address:NO.168-1-224 JULONG ROAD WUHOU DISTRICT, CHENGDU CITY,SICHUAN PROVINCE
YanCheng LongShen Chemical Co.,Ltd.
Contact:+86-515-86668866
Address:No.13,Weiyi Road,Funing Aoyang Industrial Park
Doi:10.1016/0040-4020(89)80044-4
(1989)Doi:10.1021/jo3012682
(2012)Doi:10.1016/j.tetlet.2008.03.092
(2008)Doi:10.1021/jo00014a034
(1991)Doi:10.1039/c7ob00555e
(2017)Doi:10.1021/jm00088a030
(1992)